Transcription factor GATA1 is dispensable for mast cell differentiation in adult mice

Molecular and Cellular Biology

Volumn 34, Issue 10, 2014, Pages 1812-1826

  Ohneda, Kinuko ^a   Moriguchi, Takashi ^b   Ohmori, Shin'ya ^a   Ishijima, Yasushi ^a   Satoh, Hironori ^b   Philipsen, Sjaak ^c   Yamamoto, Masayuki ^b  

^a TAKASAKI UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLCELLULOSE; SMALL INTERFERING RNA; TAMOXIFEN; TRANSCRIPTION FACTOR GATA 1; TRANSCRIPTION FACTOR GATA 2; TRYPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL FUNCTION; CHROMOSOME 17; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC TISSUE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BASE SEQUENCE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; CHROMOSOMES, MAMMALIAN; CULTURE MEDIA; GATA1 TRANSCRIPTION FACTOR; GATA2 TRANSCRIPTION FACTOR; GENE EXPRESSION REGULATION, ENZYMOLOGIC; MALE; MAST CELLS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA; TRANSCRIPTOME; TRYPTASES;

EID: 84899139943     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.01524-13     Document Type: Article

References (68)

1. Ferreira R, Ohneda K, Yamamoto M, Philipsen S. 2005. GATA1 function, a paradigm for transcription factors in hematopoiesis. Mol. Cell. Biol. 25:1215-1227. http://dx.doi.org/10.1128/MCB.25.4.1215-1227.2005.
2. Gutiérrez L, Nikolic T, van Dijk TB, Hammad H, Vos N, Willart M, Grosveld F, Philipsen S, Lambrecht BN. 2007. Gata1 regulates dendritic cell development and survival. Blood 110:1933-1941. http://dx.doi.org/10.1182/blood-2006-09-048322.
3. Fujiwara Y, Browne CP, Cunniff K, Goff SC, Orkin SH. 1996. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1. Proc. Natl. Acad. Sci. U. S. A. 93:12355-12358. http://dx.doi.org/10.1073/pnas.93.22.12355.
4. Takahashi S, Onodera K, Motohashi H, Suwabe N, Hayashi N, Yanai N, Nabesima Y, Yamamoto M. 1997. Arrest in primitive erythroid cell development caused by promoter-specific disruption of the GATA-1 gene. J. Biol. Chem. 272:12611-12615. http://dx.doi.org/10.1074/jbc.272.19.12611.
5. Gutiérrez L, Tsukamoto S, Suzuki M, Yamamoto-Mukai H, Yamamoto M, Philipsen S, Ohneda K. 2008. Ablation of Gata1 in adult mice results in aplastic crisis, revealing its essential role in steady-state and stress erythropoiesis. Blood 111:4375-4385. http://dx.doi.org/10.1182/blood-2007-09-115121.
6. Shivdasani RA, Fujiwara Y, McDevitt MA, Orkin SH. 1997. A lineageselective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development. EMBO J. 16:3965-3973. http://dx.doi.org/10.1093/emboj/16.13.3965.
7. Yu C, Cantor AB, Yang H, Browne C, Wells RA, Fujiwara Y, Orkin SH. 2002. Targeted deletion of a high-affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195:1387-1395. http://dx.doi.org/10.1084/jem.20020656.
8. Galli SJ, Tsai M. 2012. IgE and mast cells in allergic disease. Nat. Med. 18:693-704. http://dx.doi.org/10.1038/nm.2755.
9. Migliaccio AR, Rana RA, Sanchez M, Lorenzini R, Centurione L, Bianchi L, Vannucchi AM, Migliaccio G, Orkin SH. 2003. GATA-1 as a regulator of mast cell differentiation revealed by the phenotype of the GATA-1low mouse mutant. J. Exp. Med. 197:281-296. http://dx.doi.org/10.1084/jem.20021149.
10. Ghinassi B, Sanchez M, Martelli F, Amabile G, Vannucchi AM, Migliaccio G, Orkin SH, Migliaccio AR. 2007. The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 109:1460-1471. http://dx.doi.org/10.1182/blood-2006-07-030726.
11. Harigae H, Takahashi S, Suwabe N, Ohtsu H, Gu L, Yang Z, Tsai FY, Kitamura Y, Engel JD, Yamamoto M. 1998. Differential roles of GATA-1 and GATA-2 in growth and differentiation of mast cells. Genes Cells 3:39-50. http://dx.doi.org/10.1046/j.1365-2443.1998.00166.x.
12. Nishiyama C, Ito T, Nishiyama M, Masaki S, Maeda K, Nakano N, Ng W, Fukuyama K, Yamamoto M, Okumura K, Ogawa H. 2005. GATA-1 is required for expression of FceRI on mast cells: analysis of mast cells derived from GATA-1 knockdown mouse bone marrow. Int. Immunol. 17:847-856. http://dx.doi.org/10.1093/intimm/dxh278.
13. Nishiyama C, Yokota T, Okumura K, Ra C. 1999. The transcription factors Elf-1 and GATA-1 bind to cell-specific enhancer elements of human high-affinity IgE receptor alpha-chain gene. J. Immunol. 163:623-630.
14. Maeda K, Nishiyama C, Tokura T, Akizawa Y, Nishiyama M, Ogawa H, Okumura K, Ra C. 2003. Regulation of cell type-specific mouse Fc epsilon RI beta-chain gene expression by GATA-1 via four GATA motifs in the promoter. J. Immunol. 170:334-340.
15. Zon LI, Gurish MF, Stevens RL, Mather C, Reynolds DS, Austen KF, Orkin SH. 1991. GATA-binding transcription factors in mast cells regulate the promoter of the mast cell carboxypeptidase A gene. J. Biol. Chem. 266:22948-22953.
16. Ohmori S, Takai J, Ishijima Y, Suzuki M, Moriguchi T, Philipsen S, Yamamoto M, Ohneda K. 2012. Regulation of GATA factor expression is distinct between erythroid and mast cell lineages. Mol. Cell. Biol. 32:4742-4755. http://dx.doi.org/10.1128/MCB.00718-12.
17. Tsai FY, Orkin SH. 1997. Transcription factor GATA-2 is required for proliferation/survival of early hematopoietic cells and mast cell formation, but not for erythroid and myeloid terminal differentiation. Blood 89:3636-3643.
18. Takano H, Nakazawa S, Okuno Y, Shirata N, Tsuchiya S, Kainoh T, Takamatsu S, Furuta K, Taketomi Y, Naito Y, Takematsu H, Kozutsumi Y, Tsujimoto G, Murakami M, Kudo I, Ichikawa A, Nakayama K, Sugimoto Y, Tanaka S. 2008. Establishment of the culture model system that reflects the process of terminal differentiation of connective tissuetype mast cells. FEBS Lett. 582:1444-1450. http://dx.doi.org/10.1016/j.febslet.2008.03.033.
19. Bresnick EH, Lee HY, Fujiwara T, Johnson KD, Keles S. 2010. GATA switches as developmental drivers. J. Biol. Chem. 285:31087-31093. http://dx.doi.org/10.1074/jbc.R110.159079.
20. Suzuki M, Kobayashi-Osaki M, Tsutsumi S, Pan X, Ohmori S, Takai J, Moriguchi T, Ohneda O, Ohneda K, Shimizu R, Kanki Y, Kodama T, Aburatani H, Yamamoto M. 2013. GATA factor switching from GATA2 to GATA1 contributes to erythroid differentiation. Genes Cells http://dx.doi.org/10.1111/gtc.12086.
21. Grass JA, Boyer ME, Pal S, Wu J, Weiss MJ, Bresnick EH. 2003. GATA-1-dependent transcriptional repression of GATA-2 via disruption of positive autoregulation and domain-wide chromatin remodeling. Proc. Natl. Acad. Sci. U. S. A. 100:8811-8816. http://dx.doi.org/10.1073/pnas.1432147100.
22. Martowicz ML, Grass JA, Boyer ME, Guend H, Bresnick EH. 2005. DynamicGATAfactor interplay at a multicomponent regulatory region of the GATA-2 locus. J. Biol. Chem. 280:1724-1732. http://dx.doi.org/10.1074/jbc.M406038200.
23. Vyas P, McDevitt MA, Cantor AB, Katz SG, Fujiwara Y, Orkin SH. 1999. Different sequence requirements for expression in erythroid and megakaryocytic cells within a regulatory element upstream of the GATA-1 gene. Development 126:2799-2811.
24. Nishimura S, Takahashi S, Kuroha T, Suwabe N, Nagasawa T, Trainor C, Yamamoto M. 2000. A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network ofGATAfactors and sites that regulate this gene. Mol. Cell. Biol. 20:713-723. http://dx.doi.org/10.1128/MCB.20.2.713-723.2000.
25. Charles MA, Saunders TL, Wood WM, Owens K, Parlow AF, Camper SA, Ridgway EC, Gordon DF. 2006. Pituitary-specific Gata2 knockout: effects on gonadotrope and thyrotrope function. Mol. Endocrinol. 20:1366-1377. http://dx.doi.org/10.1210/me.2005-0378.
26. Ishijima Y, Ohmori S, Uenishi A, Ohneda K. 2012. GATA transcription factors are involved in IgE-dependent mast cell degranulation by enhancing the expression of phospholipase C-1. Genes Cells 17:285-301. http://dx.doi.org/10.1111/j.1365-2443.2012.01588.x.
27. Higashi AY, Ikawa T, Muramatsu M, Economides AN, Niwa A, Okuda T, Murphy AJ, Rojas J, Heike T, Nakahata T, Kawamoto H, Kita T, Yanagita M. 2009. Direct hematological toxicity and illegitimate chromosomal recombination caused by the systemic activation of CreERT2. J. Immunol. 182:5633-5640. http://dx.doi.org/10.4049/jimmunol.0802413.
28. Naiche LA, Papaioannou VE. 2007. Cre activity causes widespread apoptosis and lethal anemia during embryonic development. Genesis 45:768-775. http://dx.doi.org/10.1002/dvg.20353.
29. Salmon JM, Slater NJ, Hall MA, McCormack MP, Nutt SL, Jane SM, Curtis DJ. 2007. Aberrant mast-cell differentiation in mice lacking the stem-cell leukemia gene. Blood 110:3573-3581. http://dx.doi.org/10.1182/blood-2006-10-053124.
30. Tripic T, Deng W, Cheng Y, Zhang Y, Vakoc CR, Gregory GD, Hardison RC, Blobel GA. 2009. SCL and associated proteins distinguish active from repressive GATA transcription factor complexes. Blood 113:2191-2201. http://dx.doi.org/10.1182/blood-2008-07-169417.
31. Metcalf D, Majewski I, Mifsud S, Di Rago L, Alexander WS. 2007. Clonogenic mast cell progenitors and their excessnumbersin chimericBALB/cmice with inactivated GATA-1. Proc. Natl. Acad. Sci. U. S. A. 104:18642-18647. http://dx.doi.org/10.1073/pnas.0709625104.
32. Ronnberg E, Melo FR, Pejler G. 2012. Mast cell proteoglycans. J. Histochem. Cytochem. 60:950-962. http://dx.doi.org/10.1369/0022155412458927.
33. Mirghomizadeh F, Winoto-Morbach S, Orinska Z, Lee KH, Schutze S, Bulfone-Paus S. 2009. Intracellular IL-15 controls mast cell survival. Exp. Cell Res. 315:3064-3075. http://dx.doi.org/10.1016/j.yexcr.2009.07.019.
34. Nakajima T, Matsumoto K, Suto H, Tanaka K, Ebisawa M, Tomita H, Yuki K, Katsunuma T, Akasawa A, Hashida R, Sugita Y, Ogawa H, Ra C, Saito H. 2001. Gene expression screening of human mast cells and eosinophils using high-density oligonucleotide probe arrays: abundant expression of major basic protein in mast cells. Blood 98:1127-1134. http://dx.doi.org/10.1182/blood.V98.4.1127.
35. Lee JH, Kim YM, Kim NW, Kim JW, Her E, Kim BK, Kim JH, Ryu SH, Park JW, Seo DW, Han JW, Beaven MA, Choi WS. 2006. Phospholipase D2 acts as an essential adaptor protein in the activation of Syk in antigenstimulated mast cells. Blood 108:956-964. http://dx.doi.org/10.1182/blood-2005-10-009159.
36. Ord T, Ord D, Kuuse S, Plaas M, Ord T. 2012. Trib3 is regulated by IL-3 and affects bone marrow-derived mast cell survival and function. Cell. Immunol. 280:68-75. http://dx.doi.org/10.1016/j.cellimm.2012.11.011.
37. Prodeus AP, Zhou X, Maurer M, Galli SJ, Carroll MC. 1997. Impaired mast cell-dependent natural immunity in complement C3-deficient mice. Nature 390:172-175. http://dx.doi.org/10.1038/36586.
38. Fureder W, Agis H, Willheim M, Bankl HC, Maier U, Kishi K, Muller MR, Czerwenka K, Radaszkiewicz T, Butterfield JH, Klappacher GW, Sperr WR, Oppermann M, Lechner K, Valent P. 1995. Differential expression of complement receptors on human basophils and mast cells. Evidence for mast cell heterogeneity and CD88/C5aR expression on skin mast cells. J. Immunol. 155:3152-3160.
39. Guo Q, Subramanian H, Gupta K, Ali H. 2011. Regulation of C3a receptor signaling in human mast cells by G protein coupled receptor kinases. PLoS One 6:e22559. http://dx.doi.org/10.1371/journal.pone.0022559.
40. Saluja R, Delin I, Nilsson GP, Adner M. 2012. FeRI-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment. PLoS One 7:e43547. http://dx.doi.org/10.1371/journal.pone.0043547.
41. Burd PR, Thompson WC, Max EE, Mills FC. 1995. Activated mast cells produce interleukin 13. J. Exp. Med. 181:1373-1380. http://dx.doi.org/10.1084/jem.181.4.1373.
42. Reed JA, Albino AP, McNutt NS. 1995. Human cutaneous mast cells express basic fibroblast growth factor. Lab. Invest. 72:215-222.
43. Collington SJ, Hallgren J, Pease JE, Jones TG, Rollins BJ, Westwick J, Austen KF, Williams TJ, Gurish MF, Weller CL. 2010. The role of the CCL2/CCR2 axis in mouse mast cell migration in vitro and in vivo. J. Immunol. 184:6114-6123. http://dx.doi.org/10.4049/jimmunol.0904177.
44. Juremalm M, Nilsson G. 2005. Chemokine receptor expression by mast cells. Chem. Immunol. Allergy 87:130-144. http://dx.doi.org/10.1159/000087640.
45. Geng L, Pfister S, Kraeft SK, Rudd CE. 2001. Adaptor FYB (Fyn-binding protein) regulates integrin-mediated adhesion and mediator release: differential involvement of the FYB SH3 domain. Proc. Natl. Acad. Sci. U. S. A. 98:11527-11532. http://dx.doi.org/10.1073/pnas.191378198.
46. Vig M, DeHaven WI, Bird GS, Billingsley JM, Wang H, Rao PE, Hutchings AB, Jouvin MH, Putney JW, Kinet JP. 2008. Defective mast cell effector functions in mice lacking the CRACM1 pore subunit of storeoperated calcium release-activated calcium channels. Nat. Immunol. 9:89-96. http://dx.doi.org/10.1038/ni1550.
47. Nakamura Y, Franchi L, Kambe N, Meng G, Strober W, Nunez G. 2012. Critical role for mast cells in interleukin-1ß-driven skin inflammation associated with an activating mutation in the nlrp3 protein. Immunity. 37:85-95. http://dx.doi.org/10.1016/j.immuni.2012.04.013.
48. Kim D, Kim SH, Cho SH, Shin K, Kim S. 2011. SOCS3 suppresses the expression of IL-4 cytokine by inhibiting the phosphorylation of c-Jun through the ERK signaling pathway in rat mast cell line RBL-2H3. Mol. Immunol. 48:776-781. http://dx.doi.org/10.1016/j.molimm.2010.11.005.
49. Santos DD, Hatjiharissi E, Tournilhac O, Chemaly MZ, Leleu X, Xu L, Patterson C, Branagan AR, Manning RJ, Ho AW, Hunter ZR, Dimmock EA, Kutok JL, Churchill WH, Castells MC, Tai YT, Anderson KC, Treon SP. 2006. CD52 is expressed on human mast cells and is a potential therapeutic target in Waldenstrom's macroglobulinemia and mast cell disorders. Clin. Lymphoma Myeloma 6:478-483. http://dx.doi.org/10.3816/CLM.2006.n.029.
50. Diaz-Agustin B, Escribano L, Bravo P, Herrero S, Nunez R, Navalon R, Navarro L, Torrelo A, Cantalapiedra A, Del Castillo L, Villarrubia J, Navarro JL, San Miguel JF, Orfao A. 1999. The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease. Br. J. Haematol. 106:400-405. http://dx.doi.org/10.1046/j.1365-2141.1999.01572.x.
51. Wong GW, Yasuda S, Morokawa N, Li L, Stevens RL. 2004. Mouse chromosome 17A3.3 contains 13 genes that encode functional tryptic-like serine proteases with distinct tissue and cell expression patterns. J. Biol. Chem. 279:2438-2452. http://dx.doi.org/10.1074/jbc.M308209200.
52. Reimer JM, Samollow PB, Hellman L. 2010. High degree of conservation of the multigene tryptase locus over the past 150 to 200 million years of mammalian evolution. Immunogenetics 62:369-382. http://dx.doi.org/10.1007/s00251-010-0443-2.
53. Fujiwara T, O'Geen H, Keles S, Blahnik K, Linnemann AK, Kang YA, Choi K, Farnham PJ, Bresnick EH. 2009. Discovering hematopoietic mechanisms through genome-wide analysis of GATA factor chromatin occupancy. Mol. Cell 36:667-681. http://dx.doi.org/10.1016/j.molcel.2009.11.001.
54. Yu M, Riva L, Xie H, Schindler Y, Moran TB, Cheng Y, Yu D, Hardison R, Weiss MJ, Orkin SH, Bernstein BE, Fraenkel E, Cantor AB. 2009. Insights into GATA-1-mediated gene activation versus repression via genome-wide chromatin occupancy analysis. Mol. Cell 36:682-695. http://dx.doi.org/10.1016/j.molcel.2009.11.002.
55. Soler E, Andrieu-Soler C, de Boer E, Bryne JC, Thongjuea S, Stadhouders R, Palstra RJ, Stevens M, Kockx C, van Ijcken W, Hou J, Steinhoff C, Rijkers E, Lenhard B, Grosveld F. 2010. The genome-wide dynamics of the binding of Ldb1 complexes during erythroid differentiation. Genes Dev. 24:277-289. http://dx.doi.org/10.1101/gad.551810.
56. Masuda A, Hashimoto K, Yokoi T, Doi T, Kodama T, Kume H, Ohno K, Matsuguchi T. 2007. Essential role of GATA transcriptional factors in the activation of mast cells. J. Immunol. 178:360-368.
57. Dyer KD, Czapiga M, Foster B, Foster PS, Kang EM, Lappas CM, Moser JM, Naumann N, Percopo CM, Siegel SJ, Swartz JM, Ting-De Ravin S, Rosenberg HF. 2007. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo. J. Immunol. 179:1693-1699.
58. Takemoto CM, Brandal S, Jegga AG, Lee YN, Shahlaee A, Ying Y, Dekoter R, McDevitt MA. 2010. PU.1 positively regulates GATA-1 expression in mast cells. J. Immunol. 184:4349-4361. http://dx.doi.org/10.4049/jimmunol.0900927.
59. Thakurdas SM, Melicoff E, Sansores-Garcia L, Moreira DC, Petrova Y, Stevens RL, Adachi R. 2007. The mast cell-restricted tryptase mMCP-6 has a critical immunoprotective role in bacterial infections. J. Biol. Chem. 282:20809-20815. http://dx.doi.org/10.1074/jbc.M611842200.
60. Shin K, Watts GF, Oettgen HC, Friend DS, Pemberton AD, Gurish MF, Lee DM. 2008. Mouse mast cell tryptase mMCP-6 is a critical link between adaptive and innate immunity in the chronic phase of Trichinella spiralis infection. J. Immunol. 180:4885-4891.
61. Zhang J, Sun J, Lindholt JS, Sukhova GK, Sinnamon M, Stevens RL, Adachi R, Libby P, Thompson RW, Shi GP. 2011. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ. Res. 108:1316-1327. http://dx.doi.org/10.1161/CIRCRESAHA.111.243758.
62. Lilla JN, Chen CC, Mukai K, BenBarak MJ, Franco CB, Kalesnikoff J, Yu M, Tsai M, Piliponsky AM, Galli SJ. 2011. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 118:6930-6938. http://dx.doi.org/10.1182/blood-2011-03-343962.
63. Scholten J, Hartmann K, Gerbaulet A, Krieg T, Muller W, Testa G, Roers A. 2008. Mast cell-specific Cre/loxP-mediated recombination in vivo. Transgenic Res. 17:307-315. http://dx.doi.org/10.1007/s11248-007-9153-4.
64. Otsuka A, Kubo M, Honda T, Egawa G, Nakajima S, Tanizaki H, Kim B, Matsuoka S, Watanabe T, Nakae S, Miyachi Y, Kabashima K. 2011. Requirement of interaction between mast cells and skin dendritic cells to establish contact hypersensitivity. PLoS One 6:e25538. http://dx.doi.org/10.1371/journal.pone.0025538.
65. Kitajima K, Zheng J, Yen H, Sugiyama D, Nakano T. 2006. Multipotential differentiation ability of GATA-1-null erythroid-committed cells. Genes Dev. 20:654-659. http://dx.doi.org/10.1101/gad.1378206.
66. May G, Soneji S, Tipping AJ, Teles J, McGowan SJ, Wu M, Guo Y, Fugazza C, Brown J, Karlsson G, Pina C, Olariu V, Taylor S, Tenen DG, Peterson C, Enver T. 2013. Dynamic analysis of gene expression and genome-wide transcription factor binding during lineage specification of multipotent progenitors. Cell. Stem Cell 13:754-768. http://dx.doi.org/10.1016/j.stem.2013.09.003.
67. Cantor AB, Iwasaki H, Arinobu Y, Moran TB, Shigematsu H, Sullivan MR, Akashi K, Orkin SH. 2008. Antagonism of FOG-1 and GATA factors in fate choice for the mast cell lineage. J. Exp. Med. 205:611-624. http://dx.doi.org/10.1084/jem.20070544.
68. Arinobu Y, Iwasaki H, Gurish MF, Mizuno S, Shigematsu H, Ozawa H, Tenen DG, Austen KF, Akashi K. 2005. Developmental checkpoints of the basophil/mast cell lineages in adult murine hematopoiesis. Proc. Natl. Acad. Sci. U. S. A. 102:18105-18110. http://dx.doi.org/10.1073/pnas.0509148102.